Our findings provide the rationale for possible targeting of Notch pathway through inhibition of Hes1, which would be beneficial in modulation of the cell growth and invasive ability of GBM CSC, but not sufficient to induce CSC apoptosis. This evidence concerns the gene HES1 and glioblastoma.